Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

WASP Antikörper (pTyr290)

WAS Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated

Produktnummer ABIN2154730

Datenblatt (PDF)

Target Alle WASP (WAS) Antikörper anzeigen

WASP (WAS) (Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS))
Bindungsspezifität
15

7

7

5

5

5

4

3

3

3

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1
pTyr290
Reaktivität
73

42

12

2

1

1

1
Human
Wirt
69

4

1
Kaninchen
Passende Sekundärantikörper
Klonalität
69

5
Polyklonal
Konjugat
37

6

5

4

3

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
Dieser WASP Antikörper ist unkonjugiert
Applikation
61

36

24

15

13

13

9

6

6

5

4

1

1

1

1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Immunogen

WASP antibody was raised in Rabbit using synthesized phosphopeptide derived from human WASP around the phosphorylation site of Tyr290 as the immunogen

Isotyp

IgG

Top Product

Discover our top product WAS Primärantikörper
anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 57-170) antibody
WAS Reaktivität: Human ELISA, IHC, FACS Wirt: Maus Monoclonal 7B10E4 unconjugated

anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) antibody
WAS Reaktivität: Human WB, IF Wirt: Kaninchen Monoclonal unconjugated

anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 39-251) antibody
WAS Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (Internal Region) antibody
Verified WAS Reaktivität: Human ELISA, IHC, FACS, IF Wirt: Ziege Polyclonal unconjugated

anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 145-265) antibody
WAS Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 116-144) antibody
WAS Reaktivität: Human, Maus WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB23643 unconjugated

anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (Internal Region) antibody
WAS Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 129-156), (C-Term) antibody
WAS Reaktivität: Human, Maus, Ratte WB, IHC (p), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated

anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 205-234) antibody
WAS Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB40707 unconjugated

anti-Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS) (AA 60-250) antibody
WAS Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated

Applikationshinweise

WB: 1:500-1:1000, IHC: 1:50-1:100, ELISA: 1:1000

Beschränkungen

Nur für Forschungszwecke einsetzbar
Konzentration

Lot specific

Buffer

PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol

Konservierungsmittel

Sodium azide

Vorsichtsmaßnahmen

This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung

Store at -20 °C for 1 year

Lagerung

-20 °C

Informationen zur Lagerung

Store at -20 °C for 1 year
Target

WASP (WAS) (Wiskott-Aldrich Syndrome (Eczema-thrombocytopenia) (WAS))

Andere Bezeichnung

WASP (WAS Produkte)